RxDoctor Payments Data

Gene Harris, DO

Family Medicine · Fleming Island, FLNPI 1912926700

Payments from drug & device makers

$1,295in general payments, 2019–2025

Across 70 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$223
  • Novo Nordisk$205
  • AbbVie$193
  • Amgen$156
  • Lilly USA, LLC$97
  • AstraZeneca$87
  • plus $335 from 11 others

What the payments were for

  • Food & beverage$1,27598%
  • Education$202%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,295 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$82,303
Medicare patients
349
Services billed
885

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$48,563
EliquisApixaban33$30,779
JardianceEmpagliflozin25$25,576
EntrestoSacubitril/Valsartan19$22,804
TrulicityDulaglutide20$17,909
JanuviaSitagliptin Phosphate14$14,583
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog24$9,507
Omeprazole211$4,639
Lidocaine20$3,657
Losartan Potassium300$3,296
Albuterol Sulfate HfaAlbuterol Sulfate122$3,245
Atorvastatin Calcium289$2,987
Gabapentin128$2,951
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine55$2,903
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,532

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$205$48,56336 claims
PfizerEliquis$18$30,77933 claims
Boehringer IngelheimJardiance$16$25,57625 claims
NovartisEntresto$48$22,80419 claims
Lilly USA, LLCTrulicity$97$17,90920 claims
AbbVieSynthroid$193$2,32120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Fleming Island

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →